Andreas Vogt Selected Research

Dual-Specificity Phosphatases

1/2017	A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
2/2008	A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.
5/2005	The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
1/2005	Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Vogt Research Topics

Disease

20	Neoplasms (Cancer) 01/2019 - 01/2005
7	Breast Neoplasms (Breast Cancer) 10/2018 - 08/2009
3	Pulmonary Atelectasis 03/2013 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2019
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 08/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015 - 05/2013
2	Lung Neoplasms (Lung Cancer) 10/2009 - 08/2009
1	COVID-19 01/2021
1	Hemolytic Anemia 01/2021
1	Hyperglycemia 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Thrombosis (Thrombus) 07/2019
1	Liver Diseases (Liver Disease) 07/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Venous Thromboembolism 01/2017
1	Chronic Renal Insufficiency 01/2017
1	Hypoxia (Hypoxemia) 08/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Ischemia 01/2016
1	Parkinson Disease (Parkinson's Disease) 06/2014
1	Wounds and Injuries (Trauma) 05/2013
1	Leukemia 05/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2013
1	Hypovolemia 03/2013
1	Hypertrophy 08/2012
1	Glioma (Gliomas) 06/2012
1	Merkel Cell Carcinoma 05/2012
1	Cardiotoxicity 08/2011

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 01/2019 - 01/2004
4	Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2004
4	Dual-Specificity PhosphatasesIBA 01/2017 - 01/2005
4	Pharmaceutical PreparationsIBA 01/2017 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 04/2013 - 01/2005
3	Insulin (Novolin)FDA Link 01/2021 - 12/2019
3	TubulinIBA 01/2015 - 11/2005
3	Biological ProductsIBA 01/2014 - 06/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2011 - 11/2005
3	Excipients (Suspending Agents)IBA 06/2011 - 07/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2019
2	Profilins (Profilin)IBA 10/2018 - 01/2014
2	Mitogen-Activated Protein Kinase PhosphatasesIBA 01/2017 - 02/2008
2	Oxygen (Dioxygen)IBA 03/2013 - 06/2010
2	dictyostatinIBA 06/2011 - 11/2005
1	Investigational DrugsIBA 01/2021
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2021
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2020
1	insulin degludecIBA 01/2020
1	FructoseIBA 01/2020
1	Insulin Aspart (NovoLog)FDA Link 12/2019
1	AnticoagulantsIBA 07/2019
1	RivaroxabanIBA 07/2019
1	olaparibIBA 01/2019
1	Alkylating AgentsIBA 01/2019
1	Autocrine Motility Factor ReceptorsIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	veliparibIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	aristolochic acid I (aristolochic acid)IBA 01/2016
1	4-(phenylthio)butanoic acidIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	EstersIBA 01/2016
1	Taxoids (Taxanes)IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	AlkaloidsIBA 01/2015
1	N- (1'- naphthyl)- 3,4,5- trimethoxybenzohydrazideIBA 01/2015
1	Leucine (L-Leucine)FDA Link 06/2014
1	Colchicine FDA LinkGeneric 05/2013
1	Chalcone (Benzalacetophenone)IBA 05/2013
1	LigandsIBA 05/2013
1	ChalconesIBA 05/2013
1	VimentinIBA 04/2013
1	Cadherins (E-Cadherin)IBA 04/2013
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2013
1	benzyl isothiocyanateIBA 04/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2012
1	2-acetylpyridineIBA 06/2012
1	hydrazinecarbothioamideIBA 06/2012
1	4-nitrophenylIBA 06/2012
1	2-acetylpyridine thiosemicarbazoneIBA 06/2012
1	ThiosemicarbazonesIBA 06/2012
1	SurvivinIBA 05/2012
1	Bortezomib (Velcade)FDA Link 05/2012
1	Oncogene Proteins (Oncogene Protein)IBA 05/2012
1	sepantroniumIBA 05/2012
1	Cytostatic AgentsIBA 05/2012

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2008
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2015
1	Liver Transplantation 07/2019
1	Bariatric Surgery 01/2017
1	One-Lung Ventilation 08/2016
1	Treatment Delay 01/2016
1	Chemoprevention 04/2013